When the FDA Becomes Political, Patients’ Autonomy Suffers
Until we end the FDA’s monopoly on medical decision-making, patients will keep paying the price for politics disguised as protection.
Category: healthcare
THE END OF THE TANGLE WARS: Silkhead Kids Launches the 25 Momme OEKO-TEX Silk Pillowcase–The Ultimate Hair Wellness Essential for Children (Ages 2-6)
THE PILLOWCASE THAT DOES YOUR JOB WHILE YOU SLEEP: Silkhead Kids Launches the Highest Density 25 Momme OEKO-TEX Silk Essential. Silkhead Kids today released the ultimate low-effort solution for high-maintenance hair: the 25 Momme Pure Mulberry Silk Pillowcase. This superior, OEKO-TEX.
Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside. On October 15, Truist slashed the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $50 from $64 while maintaining a Buy rating on the shares. The rating update came as part of a broader research note previewing the fiscal […]
CT and Prospect Medical Holdings landlord clash over tax debt
The issue plays a central role in ongoing negotiations for UConn Health to acquire Waterbury Hospital, currently owned by Prospect.
医療費「月1000万円以上の患者」最多更新 健保連集計、高額治療薬が要因
医療費「月1000万円以上の患者」最多更新 健保連集計、高額治療薬が要因
「まるで拉致」強制入院 病院に300万円賠償命令 精神疾患ないのに医療保護
「まるで拉致」強制入院 病院に300万円賠償命令 精神疾患ないのに医療保護
Breakthrough Israeli AI slashes head-CT wait times, flags missed brain bleeds – exclusive
An Israeli-developed system installed on CT scanners at Assuta Medical Centers sharply shortened reporting times for suspected stroke and identified life-threatening intracranial hemorrhages.
This weight-loss solution is now India’s second-highest selling drug
Eli Lilly’s anti-obesity and diabetes drug, Mounjaro, has taken the Indian pharmaceutical market by storm.
This weight-loss solution is now India’s second-highest selling drug
Eli Lilly’s anti-obesity and diabetes drug, Mounjaro, has taken the Indian pharmaceutical market by storm.
Funding Radar: the UK and EU bring forward antimicrobial resistance research calls
Photo credits: zverge / BigStock One of the UKs largest initiatives for combating antimicrobial resistance, Pathways to Antimicrobial Clinical Efficacy (Pace), has announced up to 6 million in funding to drive new research, supporting the development of novel therapies for serious bacterial.